English
简体中文
Total: £ 56.28
Published Date: 2025-12-22 | Pages: 81 | Tables: 83 | Medical Care
The global market for Rubella Recombinant Antigen was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rubella Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of the rubella virus. Rubella virus is the virus that causes rubella, a common infectious disease that is particularly dangerous in pregnant women because infection may lead to congenital rubella syndrome in the fetus. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by rubella infection (such as the presence of antibodies), and are used in vaccine development and basic research.
North American market for Rubella Recombinant Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rubella Recombinant Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rubella Recombinant Antigen in In Vitro Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rubella Recombinant Antigen include Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rubella Recombinant Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Recombinant Antigen.
The Rubella Recombinant Antigen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rubella Recombinant Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Recombinant Antigen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biomart
RayBiotech
ProSpec
Abcam
Bio-Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation
Segment by Type
Rubella Protein Purity >90%
Rubella Protein Purity >95%
Rubella Protein Purity >98%
Others
Segment by Application
In Vitro Diagnostics
Vaccine Development
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rubella Recombinant Antigen company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Recombinant Antigen Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rubella Protein Purity >90%
1.2.3 Rubella Protein Purity >95%
1.2.4 Rubella Protein Purity >98%
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rubella Recombinant Antigen Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In Vitro Diagnostics
1.3.3 Vaccine Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Recombinant Antigen Market Perspective (2020-2031)
2.2 Global Rubella Recombinant Antigen Growth Trends by Region
2.2.1 Global Rubella Recombinant Antigen Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rubella Recombinant Antigen Historic Market Size by Region (2020-2025)
2.2.3 Rubella Recombinant Antigen Forecasted Market Size by Region (2026-2031)
2.3 Rubella Recombinant Antigen Market Dynamics
2.3.1 Rubella Recombinant Antigen Industry Trends
2.3.2 Rubella Recombinant Antigen Market Drivers
2.3.3 Rubella Recombinant Antigen Market Challenges
2.3.4 Rubella Recombinant Antigen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Recombinant Antigen Players by Revenue
3.1.1 Global Top Rubella Recombinant Antigen Players by Revenue (2020-2025)
3.1.2 Global Rubella Recombinant Antigen Revenue Market Share by Players (2020-2025)
3.2 Global Rubella Recombinant Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rubella Recombinant Antigen Revenue
3.4 Global Rubella Recombinant Antigen Market Concentration Ratio
3.4.1 Global Rubella Recombinant Antigen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Recombinant Antigen Revenue in 2024
3.5 Global Key Players of Rubella Recombinant Antigen Head office and Area Served
3.6 Global Key Players of Rubella Recombinant Antigen, Product and Application
3.7 Global Key Players of Rubella Recombinant Antigen, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Recombinant Antigen Breakdown Data by Type
4.1 Global Rubella Recombinant Antigen Historic Market Size by Type (2020-2025)
4.2 Global Rubella Recombinant Antigen Forecasted Market Size by Type (2026-2031)
5 Rubella Recombinant Antigen Breakdown Data by Application
5.1 Global Rubella Recombinant Antigen Historic Market Size by Application (2020-2025)
5.2 Global Rubella Recombinant Antigen Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rubella Recombinant Antigen Market Size (2020-2031)
6.2 North America Rubella Recombinant Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rubella Recombinant Antigen Market Size by Country (2020-2025)
6.4 North America Rubella Recombinant Antigen Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Recombinant Antigen Market Size (2020-2031)
7.2 Europe Rubella Recombinant Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rubella Recombinant Antigen Market Size by Country (2020-2025)
7.4 Europe Rubella Recombinant Antigen Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Recombinant Antigen Market Size (2020-2031)
8.2 Asia-Pacific Rubella Recombinant Antigen Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2020-2025)
8.4 Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Recombinant Antigen Market Size (2020-2031)
9.2 Latin America Rubella Recombinant Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rubella Recombinant Antigen Market Size by Country (2020-2025)
9.4 Latin America Rubella Recombinant Antigen Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Recombinant Antigen Market Size (2020-2031)
10.2 Middle East & Africa Rubella Recombinant Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2020-2025)
10.4 Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biomart
11.1.1 Creative Biomart Company Details
11.1.2 Creative Biomart Business Overview
11.1.3 Creative Biomart Rubella Recombinant Antigen Introduction
11.1.4 Creative Biomart Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.1.5 Creative Biomart Recent Development
11.2 RayBiotech
11.2.1 RayBiotech Company Details
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech Rubella Recombinant Antigen Introduction
11.2.4 RayBiotech Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.2.5 RayBiotech Recent Development
11.3 ProSpec
11.3.1 ProSpec Company Details
11.3.2 ProSpec Business Overview
11.3.3 ProSpec Rubella Recombinant Antigen Introduction
11.3.4 ProSpec Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.3.5 ProSpec Recent Development
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Rubella Recombinant Antigen Introduction
11.4.4 Abcam Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.4.5 Abcam Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Rubella Recombinant Antigen Introduction
11.5.4 Bio-Rad Laboratories Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Fapon Biotech
11.6.1 Fapon Biotech Company Details
11.6.2 Fapon Biotech Business Overview
11.6.3 Fapon Biotech Rubella Recombinant Antigen Introduction
11.6.4 Fapon Biotech Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.6.5 Fapon Biotech Recent Development
11.7 QED Bioscience
11.7.1 QED Bioscience Company Details
11.7.2 QED Bioscience Business Overview
11.7.3 QED Bioscience Rubella Recombinant Antigen Introduction
11.7.4 QED Bioscience Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.7.5 QED Bioscience Recent Development
11.8 Cusabio
11.8.1 Cusabio Company Details
11.8.2 Cusabio Business Overview
11.8.3 Cusabio Rubella Recombinant Antigen Introduction
11.8.4 Cusabio Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.8.5 Cusabio Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Rubella Recombinant Antigen Introduction
11.9.4 Meridian Bioscience Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.9.5 Meridian Bioscience Recent Development
11.10 Native Antigen Company
11.10.1 Native Antigen Company Company Details
11.10.2 Native Antigen Company Business Overview
11.10.3 Native Antigen Company Rubella Recombinant Antigen Introduction
11.10.4 Native Antigen Company Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.10.5 Native Antigen Company Recent Development
11.11 SERION Immunologics
11.11.1 SERION Immunologics Company Details
11.11.2 SERION Immunologics Business Overview
11.11.3 SERION Immunologics Rubella Recombinant Antigen Introduction
11.11.4 SERION Immunologics Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.11.5 SERION Immunologics Recent Development
11.12 ViroGen Corporation
11.12.1 ViroGen Corporation Company Details
11.12.2 ViroGen Corporation Business Overview
11.12.3 ViroGen Corporation Rubella Recombinant Antigen Introduction
11.12.4 ViroGen Corporation Revenue in Rubella Recombinant Antigen Business (2020-2025)
11.12.5 ViroGen Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rubella Recombinant Antigen Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Rubella Protein Purity >90%
Table 3. Key Players of Rubella Protein Purity >95%
Table 4. Key Players of Rubella Protein Purity >98%
Table 5. Key Players of Others
Table 6. Global Rubella Recombinant Antigen Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rubella Recombinant Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Rubella Recombinant Antigen Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Rubella Recombinant Antigen Market Share by Region (2020-2025)
Table 10. Global Rubella Recombinant Antigen Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Rubella Recombinant Antigen Market Share by Region (2026-2031)
Table 12. Rubella Recombinant Antigen Market Trends
Table 13. Rubella Recombinant Antigen Market Drivers
Table 14. Rubella Recombinant Antigen Market Challenges
Table 15. Rubella Recombinant Antigen Market Restraints
Table 16. Global Rubella Recombinant Antigen Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Rubella Recombinant Antigen Market Share by Players (2020-2025)
Table 18. Global Top Rubella Recombinant Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Recombinant Antigen as of 2024)
Table 19. Ranking of Global Top Rubella Recombinant Antigen Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Rubella Recombinant Antigen Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Rubella Recombinant Antigen, Headquarters and Area Served
Table 22. Global Key Players of Rubella Recombinant Antigen, Product and Application
Table 23. Global Key Players of Rubella Recombinant Antigen, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rubella Recombinant Antigen Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Rubella Recombinant Antigen Revenue Market Share by Type (2020-2025)
Table 27. Global Rubella Recombinant Antigen Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Rubella Recombinant Antigen Revenue Market Share by Type (2026-2031)
Table 29. Global Rubella Recombinant Antigen Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Rubella Recombinant Antigen Revenue Market Share by Application (2020-2025)
Table 31. Global Rubella Recombinant Antigen Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Rubella Recombinant Antigen Revenue Market Share by Application (2026-2031)
Table 33. North America Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Rubella Recombinant Antigen Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Rubella Recombinant Antigen Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Rubella Recombinant Antigen Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Rubella Recombinant Antigen Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Rubella Recombinant Antigen Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Rubella Recombinant Antigen Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rubella Recombinant Antigen Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2026-2031) & (US$ Million)
Table 48. Creative Biomart Company Details
Table 49. Creative Biomart Business Overview
Table 50. Creative Biomart Rubella Recombinant Antigen Product
Table 51. Creative Biomart Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 52. Creative Biomart Recent Development
Table 53. RayBiotech Company Details
Table 54. RayBiotech Business Overview
Table 55. RayBiotech Rubella Recombinant Antigen Product
Table 56. RayBiotech Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 57. RayBiotech Recent Development
Table 58. ProSpec Company Details
Table 59. ProSpec Business Overview
Table 60. ProSpec Rubella Recombinant Antigen Product
Table 61. ProSpec Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 62. ProSpec Recent Development
Table 63. Abcam Company Details
Table 64. Abcam Business Overview
Table 65. Abcam Rubella Recombinant Antigen Product
Table 66. Abcam Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 67. Abcam Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Rubella Recombinant Antigen Product
Table 71. Bio-Rad Laboratories Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. Fapon Biotech Company Details
Table 74. Fapon Biotech Business Overview
Table 75. Fapon Biotech Rubella Recombinant Antigen Product
Table 76. Fapon Biotech Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 77. Fapon Biotech Recent Development
Table 78. QED Bioscience Company Details
Table 79. QED Bioscience Business Overview
Table 80. QED Bioscience Rubella Recombinant Antigen Product
Table 81. QED Bioscience Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 82. QED Bioscience Recent Development
Table 83. Cusabio Company Details
Table 84. Cusabio Business Overview
Table 85. Cusabio Rubella Recombinant Antigen Product
Table 86. Cusabio Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 87. Cusabio Recent Development
Table 88. Meridian Bioscience Company Details
Table 89. Meridian Bioscience Business Overview
Table 90. Meridian Bioscience Rubella Recombinant Antigen Product
Table 91. Meridian Bioscience Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 92. Meridian Bioscience Recent Development
Table 93. Native Antigen Company Company Details
Table 94. Native Antigen Company Business Overview
Table 95. Native Antigen Company Rubella Recombinant Antigen Product
Table 96. Native Antigen Company Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 97. Native Antigen Company Recent Development
Table 98. SERION Immunologics Company Details
Table 99. SERION Immunologics Business Overview
Table 100. SERION Immunologics Rubella Recombinant Antigen Product
Table 101. SERION Immunologics Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 102. SERION Immunologics Recent Development
Table 103. ViroGen Corporation Company Details
Table 104. ViroGen Corporation Business Overview
Table 105. ViroGen Corporation Rubella Recombinant Antigen Product
Table 106. ViroGen Corporation Revenue in Rubella Recombinant Antigen Business (2020-2025) & (US$ Million)
Table 107. ViroGen Corporation Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Rubella Recombinant Antigen Picture
Figure 2. Global Rubella Recombinant Antigen Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rubella Recombinant Antigen Market Share by Type: 2024 VS 2031
Figure 4. Rubella Protein Purity >90% Features
Figure 5. Rubella Protein Purity >95% Features
Figure 6. Rubella Protein Purity >98% Features
Figure 7. Others Features
Figure 8. Global Rubella Recombinant Antigen Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Rubella Recombinant Antigen Market Share by Application: 2024 VS 2031
Figure 10. In Vitro Diagnostics Case Studies
Figure 11. Vaccine Development Case Studies
Figure 12. Others Case Studies
Figure 13. Rubella Recombinant Antigen Report Years Considered
Figure 14. Global Rubella Recombinant Antigen Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Rubella Recombinant Antigen Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Rubella Recombinant Antigen Market Share by Region: 2024 VS 2031
Figure 17. Global Rubella Recombinant Antigen Market Share by Players in 2024
Figure 18. Global Top Rubella Recombinant Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Recombinant Antigen as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Rubella Recombinant Antigen Revenue in 2024
Figure 20. North America Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Rubella Recombinant Antigen Market Share by Country (2020-2031)
Figure 22. United States Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Rubella Recombinant Antigen Market Share by Country (2020-2031)
Figure 26. Germany Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Rubella Recombinant Antigen Market Share by Region (2020-2031)
Figure 34. China Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Rubella Recombinant Antigen Market Share by Country (2020-2031)
Figure 42. Mexico Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Rubella Recombinant Antigen Market Share by Country (2020-2031)
Figure 46. Turkey Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Rubella Recombinant Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Creative Biomart Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 50. RayBiotech Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 51. ProSpec Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 52. Abcam Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 54. Fapon Biotech Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 55. QED Bioscience Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 56. Cusabio Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 57. Meridian Bioscience Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 58. Native Antigen Company Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 59. SERION Immunologics Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 60. ViroGen Corporation Revenue Growth Rate in Rubella Recombinant Antigen Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
